Production (Stage)
HOOKIPA Pharma Inc.
HOOK
$1.53
-$0.03-1.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -82.54% | 118.32% | 143.30% | 227.80% | 235.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -82.54% | 118.32% | 143.30% | 227.80% | 235.12% |
| Cost of Revenue | -38.03% | -27.62% | -10.19% | 16.30% | -9.24% |
| Gross Profit | -171.74% | 92.11% | 86.25% | 68.32% | 79.54% |
| SG&A Expenses | 27.68% | 8.11% | 4.82% | -4.63% | -4.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.55% | -15.54% | -5.14% | 8.84% | 12.88% |
| Operating Income | -50.12% | 47.26% | 43.09% | 35.42% | 34.06% |
| Income Before Tax | -55.05% | 46.30% | 37.05% | 28.62% | 28.46% |
| Income Tax Expenses | -164.63% | -128.73% | -62.21% | -62.21% | -62.30% |
| Earnings from Continuing Operations | -54.29% | 46.67% | 37.21% | 28.84% | 28.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.29% | 46.67% | 37.21% | 28.84% | 28.68% |
| EBIT | -50.12% | 47.26% | 43.09% | 35.42% | 34.06% |
| EBITDA | -55.28% | 48.35% | 45.06% | 36.61% | 35.44% |
| EPS Basic | -17.78% | 60.65% | 55.76% | 52.83% | 46.17% |
| Normalized Basic EPS | -45.64% | 61.44% | 71.58% | 66.31% | 59.43% |
| EPS Diluted | -17.70% | 60.64% | 55.75% | 52.82% | 46.13% |
| Normalized Diluted EPS | -45.64% | 61.44% | 71.58% | 66.31% | 59.43% |
| Average Basic Shares Outstanding | 16.15% | 32.80% | 44.96% | 58.41% | 49.41% |
| Average Diluted Shares Outstanding | 16.15% | 32.80% | 44.96% | 58.41% | 49.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |